{"id":"https://openalex.org/W7214629664","doi":"https://doi.org/10.1002/bit.70389","title":"Implementing an Intensified Dynamic Perfusion Process for Biologics Manufacturing at Scale and Continued Development","display_name":"Implementing an Intensified Dynamic Perfusion Process for Biologics Manufacturing at Scale and Continued Development","publication_year":2026,"publication_date":"2026-09-27","ids":{"openalex":"https://openalex.org/W7214629664","doi":"https://doi.org/10.1002/bit.70389","pmid":"https://pubmed.ncbi.nlm.nih.gov/42802679"},"language":"en","primary_location":{"id":"doi:10.1002/bit.70389","doi":"https://doi.org/10.1002/bit.70389","is_oa":true,"landing_page_url":"https://doi.org/10.1002/bit.70389","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/bit.70389","source":{"id":"https://openalex.org/S151564723","display_name":"Biotechnology and Bioengineering","issn_l":"0006-3592","issn":["0006-3592","1097-0290"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biotechnology and Bioengineering","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/bit.70389","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5153238031","display_name":"Jennifer Nguyen","orcid":"https://orcid.org/0009-0005-6706-2294","observed_orcids":["https://orcid.org/0009-0005-6706-2294"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer Nguyen","raw_affiliation_strings":["Bioprocess Research and Development, Pfizer Inc Andover Massachusetts USA"],"raw_orcid":"https://orcid.org/0009-0005-6706-2294","affiliations":[{"raw_affiliation_string":"Bioprocess Research and Development, Pfizer Inc Andover Massachusetts USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113181917","display_name":"Alaina Anand","orcid":"https://orcid.org/0009-0006-9904-7424","observed_orcids":["https://orcid.org/0009-0006-9904-7424"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alaina Anand","raw_affiliation_strings":["Bioprocess Research and Development, Pfizer Inc Andover Massachusetts USA"],"raw_orcid":"https://orcid.org/0009-0006-9904-7424","affiliations":[{"raw_affiliation_string":"Bioprocess Research and Development, Pfizer Inc Andover Massachusetts USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5153236261","display_name":"Meghan Sullivan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Meghan Sullivan","raw_affiliation_strings":["Bioprocess Research and Development, Pfizer Inc Andover Massachusetts USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bioprocess Research and Development, Pfizer Inc Andover Massachusetts USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101594974","display_name":"Wenge Wang","orcid":"https://orcid.org/0000-0001-5740-5912","observed_orcids":["https://orcid.org/0000-0001-5740-5912"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wenge Wang","raw_affiliation_strings":["Bioprocess Research and Development, Pfizer Inc Andover Massachusetts USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bioprocess Research and Development, Pfizer Inc Andover Massachusetts USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5153216160","display_name":"Spencer Barr","orcid":"https://orcid.org/0009-0009-0706-2224","observed_orcids":["https://orcid.org/0009-0009-0706-2224"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Spencer Barr","raw_affiliation_strings":["Bioprocess Research and Development, Pfizer Inc Andover Massachusetts USA"],"raw_orcid":"https://orcid.org/0009-0009-0706-2224","affiliations":[{"raw_affiliation_string":"Bioprocess Research and Development, Pfizer Inc Andover Massachusetts USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5153239006","display_name":"Jos\u00e9 Gomes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jos\u00e9 Gomes","raw_affiliation_strings":["Bioprocess Research and Development, Pfizer Inc Andover Massachusetts USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bioprocess Research and Development, Pfizer Inc Andover Massachusetts USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084249772","display_name":"Alessandra Molinaro","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alessandra Molinaro","raw_affiliation_strings":["Bioprocess Research and Development, Pfizer Inc Andover Massachusetts USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bioprocess Research and Development, Pfizer Inc Andover Massachusetts USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111631852","display_name":"Greg Porter","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Greg Porter","raw_affiliation_strings":["Bioprocess Research and Development, Pfizer Inc Andover Massachusetts USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bioprocess Research and Development, Pfizer Inc Andover Massachusetts USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068943318","display_name":"Matthew Gagnon","orcid":"https://orcid.org/0000-0002-0386-0562","observed_orcids":["https://orcid.org/0000-0002-0386-0562"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Matthew Gagnon","raw_affiliation_strings":["Bioprocess Research and Development, Pfizer Inc Andover Massachusetts USA"],"raw_orcid":"https://orcid.org/0000-0002-0386-0562","affiliations":[{"raw_affiliation_string":"Bioprocess Research and Development, Pfizer Inc Andover Massachusetts USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5088851749","display_name":"Aravindan Rajendran","orcid":"https://orcid.org/0000-0001-6800-2537","observed_orcids":["https://orcid.org/0000-0001-6800-2537"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Aravindan Rajendran","raw_affiliation_strings":["Bioprocess Research and Development, Pfizer Inc Andover Massachusetts USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bioprocess Research and Development, Pfizer Inc Andover Massachusetts USA","institution_ids":["https://openalex.org/I180857899"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5068943318","https://openalex.org/A5088851749"],"corresponding_institution_ids":["https://openalex.org/I180857899"],"apc_list":{"value":5060,"currency":"USD","value_usd":5060},"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11663","display_name":"Viral Infectious Diseases and Gene Expression in Insects","score":0.9589999914169312,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11663","display_name":"Viral Infectious Diseases and Gene Expression in Insects","score":0.9589999914169312,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11124","display_name":"Protein purification and stability","score":0.02879999950528145,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.003000000026077032,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/perfusion-culture","display_name":"perfusion culture","score":0.8679999709129333},{"id":"https://openalex.org/keywords/antibody-production","display_name":"antibody production","score":0.7120000123977661},{"id":"https://openalex.org/keywords/cho-cells","display_name":"CHO cells","score":0.6809999942779541},{"id":"https://openalex.org/keywords/crossflow-filtration","display_name":"cross-flow filtration","score":0.984000027179718},{"id":"https://openalex.org/keywords/membrane-fouling","display_name":"membrane fouling","score":0.9800000190734863},{"id":"https://openalex.org/keywords/scale-up","display_name":"scale-up","score":0.6650000214576721},{"id":"https://openalex.org/keywords/continuous-bioprocessing","display_name":"continuous bioprocessing","score":0.7580000162124634},{"id":"https://openalex.org/keywords/product-recovery","display_name":"product recovery","score":0.6110000014305115},{"id":"https://openalex.org/keywords/space-time-yield","display_name":"space-time yield","score":0.9309999942779541},{"id":"https://openalex.org/keywords/transmembrane-pressure","display_name":"transmembrane pressure","score":0.7979999780654907},{"id":"https://openalex.org/keywords/biopharmaceutical-manufacturing","display_name":"biopharmaceutical manufacturing","score":0.7229999899864197}],"concepts":[{"id":"https://openalex.org/C21880701","wikidata":"https://www.wikidata.org/wiki/Q2144042","display_name":"Process engineering","level":1,"score":0.6539000272750854},{"id":"https://openalex.org/C146957229","wikidata":"https://www.wikidata.org/wiki/Q1266915","display_name":"Perfusion","level":2,"score":0.5356000065803528},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.48969998955726624},{"id":"https://openalex.org/C128489963","wikidata":"https://www.wikidata.org/wiki/Q1187724","display_name":"Filtration (mathematics)","level":2,"score":0.4514999985694885},{"id":"https://openalex.org/C136229726","wikidata":"https://www.wikidata.org/wiki/Q327092","display_name":"Biomedical engineering","level":1,"score":0.41929998993873596},{"id":"https://openalex.org/C53163501","wikidata":"https://www.wikidata.org/wiki/Q1141078","display_name":"Cross-flow filtration","level":3,"score":0.41499999165534973},{"id":"https://openalex.org/C48044578","wikidata":"https://www.wikidata.org/wiki/Q727490","display_name":"Scalability","level":2,"score":0.41370001435279846},{"id":"https://openalex.org/C63479239","wikidata":"https://www.wikidata.org/wiki/Q7353546","display_name":"Robustness (evolution)","level":3,"score":0.4004000127315521},{"id":"https://openalex.org/C180461467","wikidata":"https://www.wikidata.org/wiki/Q2623659","display_name":"Membrane fouling","level":4,"score":0.39660000801086426},{"id":"https://openalex.org/C98045186","wikidata":"https://www.wikidata.org/wiki/Q205663","display_name":"Process (computing)","level":2,"score":0.38519999384880066},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.36730000376701355},{"id":"https://openalex.org/C183696295","wikidata":"https://www.wikidata.org/wiki/Q2487696","display_name":"Biochemical engineering","level":1,"score":0.3537999987602234},{"id":"https://openalex.org/C41625074","wikidata":"https://www.wikidata.org/wiki/Q176088","display_name":"Membrane","level":2,"score":0.33889999985694885},{"id":"https://openalex.org/C137981799","wikidata":"https://www.wikidata.org/wiki/Q1369184","display_name":"Reusability","level":3,"score":0.31790000200271606},{"id":"https://openalex.org/C115792997","wikidata":"https://www.wikidata.org/wiki/Q1439803","display_name":"Fouling","level":3,"score":0.31380000710487366},{"id":"https://openalex.org/C2777874358","wikidata":"https://www.wikidata.org/wiki/Q7389060","display_name":"SCALE-UP","level":2,"score":0.31360000371932983},{"id":"https://openalex.org/C168170006","wikidata":"https://www.wikidata.org/wiki/Q864699","display_name":"Bioreactor","level":2,"score":0.30720001459121704},{"id":"https://openalex.org/C55396564","wikidata":"https://www.wikidata.org/wiki/Q3084971","display_name":"Process design","level":3,"score":0.3066999912261963},{"id":"https://openalex.org/C2778755073","wikidata":"https://www.wikidata.org/wiki/Q10858537","display_name":"Scale (ratio)","level":2,"score":0.28929999470710754},{"id":"https://openalex.org/C2780434155","wikidata":"https://www.wikidata.org/wiki/Q7247767","display_name":"Product inhibition","level":4,"score":0.2879999876022339},{"id":"https://openalex.org/C2992270614","wikidata":"https://www.wikidata.org/wiki/Q29548","display_name":"Membrane permeability","level":3,"score":0.28790000081062317},{"id":"https://openalex.org/C2778348673","wikidata":"https://www.wikidata.org/wiki/Q739302","display_name":"Production (economics)","level":2,"score":0.28450000286102295},{"id":"https://openalex.org/C101468663","wikidata":"https://www.wikidata.org/wiki/Q1620158","display_name":"Modular design","level":2,"score":0.2703000009059906},{"id":"https://openalex.org/C89008666","wikidata":"https://www.wikidata.org/wiki/Q1340858","display_name":"Final product","level":2,"score":0.2639999985694885},{"id":"https://openalex.org/C99862985","wikidata":"https://www.wikidata.org/wiki/Q10858068","display_name":"Production line","level":2,"score":0.2639000117778778},{"id":"https://openalex.org/C90673727","wikidata":"https://www.wikidata.org/wiki/Q901718","display_name":"Product (mathematics)","level":2,"score":0.257999986410141},{"id":"https://openalex.org/C18762648","wikidata":"https://www.wikidata.org/wiki/Q42213","display_name":"Work (physics)","level":2,"score":0.25760000944137573},{"id":"https://openalex.org/C2780548022","wikidata":"https://www.wikidata.org/wiki/Q614396","display_name":"Continuous production","level":2,"score":0.25679999589920044},{"id":"https://openalex.org/C117671659","wikidata":"https://www.wikidata.org/wiki/Q11049265","display_name":"Manufacturing engineering","level":1,"score":0.2565999925136566},{"id":"https://openalex.org/C19351080","wikidata":"https://www.wikidata.org/wiki/Q1395034","display_name":"New product development","level":2,"score":0.2502000033855438}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1002/bit.70389","doi":"https://doi.org/10.1002/bit.70389","is_oa":true,"landing_page_url":"https://doi.org/10.1002/bit.70389","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/bit.70389","source":{"id":"https://openalex.org/S151564723","display_name":"Biotechnology and Bioengineering","issn_l":"0006-3592","issn":["0006-3592","1097-0290"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biotechnology and Bioengineering","raw_type":"journal-article"},{"id":"pmid:42802679","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42802679","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biotechnology and bioengineering","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1002/bit.70389","doi":"https://doi.org/10.1002/bit.70389","is_oa":true,"landing_page_url":"https://doi.org/10.1002/bit.70389","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/bit.70389","source":{"id":"https://openalex.org/S151564723","display_name":"Biotechnology and Bioengineering","issn_l":"0006-3592","issn":["0006-3592","1097-0290"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biotechnology and Bioengineering","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.4000000059604645,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7214629664.pdf","grobid_xml":"https://content.openalex.org/works/W7214629664.grobid-xml"},"referenced_works_count":30,"referenced_works":["https://openalex.org/W940673965","https://openalex.org/W1866080720","https://openalex.org/W1981014445","https://openalex.org/W2006512810","https://openalex.org/W2082568784","https://openalex.org/W2084219873","https://openalex.org/W2121600510","https://openalex.org/W2560383276","https://openalex.org/W2580352042","https://openalex.org/W2584138789","https://openalex.org/W2738538457","https://openalex.org/W2764315405","https://openalex.org/W2788544221","https://openalex.org/W2800956912","https://openalex.org/W2885737412","https://openalex.org/W2887576458","https://openalex.org/W2897121698","https://openalex.org/W3042329320","https://openalex.org/W3092384902","https://openalex.org/W3142218559","https://openalex.org/W3215495644","https://openalex.org/W4385263978","https://openalex.org/W4390059959","https://openalex.org/W4390713549","https://openalex.org/W4391740954","https://openalex.org/W4391932815","https://openalex.org/W4394693699","https://openalex.org/W4396639968","https://openalex.org/W4411121084","https://openalex.org/W7134265695"],"related_works":["https://openalex.org/W2897121698","https://openalex.org/W7128890589","https://openalex.org/W2159917989","https://openalex.org/W3165980606","https://openalex.org/W2623375155","https://openalex.org/W7024948194","https://openalex.org/W3037516759","https://openalex.org/W4402610749","https://openalex.org/W3015085465","https://openalex.org/W2060385448"],"abstract_inverted_index":{"Perfusion":[0],"cell":[1,90,116],"culture":[2],"is":[3],"increasingly":[4],"adopted":[5],"to":[6,48],"improve":[7],"productivity,":[8],"reduce":[9],"footprint,":[10],"and":[11,32,41,100,135,149,166,184,190],"enable":[12],"integrated":[13],"continuous":[14],"bioprocessing.":[15],"The":[16,54],"high-intensity,":[17],"low-volume":[18],"perfusion":[19,64,138,171,198],"(HILVOP)":[20],"process":[21,56],"for":[22,37],"antibody":[23],"production":[24,76],"was":[25,44,85],"implemented":[26],"at":[27],"both":[28],"100":[29],"L":[30,34],"pilot":[31],"500":[33],"manufacturing":[35,104],"scales":[36],"early":[38],"clinical":[39],"supply,":[40],"development":[42],"work":[43],"completed":[45],"in":[46,174],"tandem":[47],"create":[49],"a":[50,58,93,110],"next-generation":[51],"HILVOP":[52,55,188],"platform.":[53],"employs":[57],"dynamic":[59],"two\u2011stage":[60],"strategy,":[61],"using":[62],"cell\u2011controlled":[63],"during":[65,73],"the":[66,74,169,182,187],"growth":[67],"phase":[68,77],"followed":[69],"by":[70],"product":[71,98,152],"removal":[72],"intensified":[75],"via":[78],"tangential":[79],"flow":[80],"filtration":[81],"(TFF).":[82],"Scale\u2011up":[83],"performance":[84],"evaluated":[86],"across":[87],"multiple":[88],"CHO":[89],"lines":[91],"with":[92,114],"focus":[94],"on":[95],"membrane":[96,107,125,142],"robustness,":[97],"recovery,":[99],"space\u2011time":[101,177],"yield.":[102,178],"Early":[103],"runs":[105],"identified":[106],"fouling":[108],"as":[109],"key":[111,192],"risk,":[112],"particularly":[113],"challenging":[115],"lines.":[117],"Systematic":[118],"optimization":[119],"of":[120,137,168,186],"TFF":[121],"operating":[122],"conditions":[123],"(reduced":[124],"wall":[126],"shear":[127],"rate,":[128],"larger":[129],"pore":[130],"size,":[131],"alternative":[132],"filter":[133],"membrane,":[134],"refinement":[136],"rate":[139],"profiles)":[140],"improved":[141],"performance,":[143],"delayed":[144],"transmembrane":[145],"pressure":[146],"(TMP)":[147],"rise,":[148],"increased":[150,175],"cumulative":[151],"recovery":[153],"while":[154],"reducing":[155],"media":[156],"consumption.":[157],"Additional":[158],"productivity":[159],"gains":[160],"were":[161],"achieved":[162],"through":[163],"high\u2011density":[164],"seeding":[165],"extension":[167],"productive":[170],"phase,":[172],"resulting":[173],"permeate":[176],"These":[179],"results":[180],"demonstrate":[181],"robustness":[183],"scalability":[185],"platform":[189],"highlight":[191],"design":[193],"considerations":[194],"enabling":[195],"reliable":[196],"manufacturing\u2011scale":[197],"operation.":[199]},"counts_by_year":[],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2026-09-29T00:00:00"}